Glide Pharma was awarded Best Medtech Fundraiser at the OBN’s Annual Awards Dinner on 02 October 2013. The Awards seek to highlight the many achievements of the UK’s bioscience sector in raising funds, executing deals and supporting innovation. OBN’s Awards recognise these achievements, taking into account its significance for the stage of development of a nominated life sciences company, as well as the scale of the achievement.
Glide Pharma raised £14m in Feb 2013 from Invesco Perpetual and existing investors which will enable the scale-up of manufacturing for its Glide SDI® injector system (both drug and device). Glide won an additional £2.3m of project funding from TSB in the form of a Biomedical Catalyst competition award.